<DOC>
	<DOCNO>NCT00621998</DOCNO>
	<brief_summary>We initiate study research grant department health Taoyuan mental hospital choose risperidone olanzapine study medication . We compare effect 2 drug schizophrenic spectrum patient Han ethnic neuroleptic-induced tardive dyskinesia test hypothesis two medication different effect improve tardive dyskinesia .</brief_summary>
	<brief_title>Risperidone Olanzapine Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia</brief_title>
	<detailed_description>Objective : First generation antipsychotic would induce tardive dyskinesia schizophrenic patient . Second generation antipsychotic choice patient . But one second generation antipsychotic good choice definitive result . We compare risperidone olanzapine schizophrenic patient neuroleptic-induced tardive dyskinesia see effect improve tardive dyskinesia . We also collect data average dose risperidone olanzapine help dose strategy guideline schizophrenic patient neuroleptic-induced tardive dyskinesia . Method : This randomize , rater-blind , parallel group , flexible dose study enrol patient Taoyuan Mental Hospital July 2000 December 2003 . Schizophrenia , schizophreniform schizoaffective disorder ( DSM-IV ) patient meet research criterion neuroleptic-induced tardive dyskinesia research criteria DSM-IV le moderate severity ( ＞ =4 ) global impression extrapyramidal syndrome rating scale ( ESRS ) . 60 patient random assignment risperidone olanzapine 24 week . The primary outcome compare change total score abnormal involuntary movement scale baseline study endpoint .</detailed_description>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Age 1870 y/o Female patient pregnancy plan must agree use reliable pregnancy prevention method childbearing age Meet schizophrenia , schizophreniform schizoaffective disorder criterion DSMIV Fulfill DSMIV neurolepticinduced tardive dyskinesia research criterion , severity tardive dyskinesia less moderate degree ( ＞ =4 ) assess global impression Extrapyramidal System Rating Scale ( item 42 ESRS ) Patients legal responsible people agree join study sign inform consent Had axis I diagnosis DSMIV Unstable major systemic disease Had neurological disorder influence EPS assessment Substance abuse dependence coffee tobacco within 6 month study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2000</verification_date>
	<keyword>Risperidone</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Tardive dyskinesia</keyword>
</DOC>